confirmed the significant cytotoxicity of MUC16 ectodomain-specific bispecific single-chain variable fragments (BiTEDs) against ovarian cancer cells in vitro, effectively delaying tumor progression in vivo, especially when combined with anti-angiogenic treatment, showing potential for extending survival (147). The gene discussed is MUC16; the disease is ovarian cancer.